Cannabis-derived drugs such as CBD oil have soared in popularity in recent years, amid increased recognition for their medical usages.
In fact, the number of people using CBD oil, also known as cannabidiol, in the UK alone is estimated to stand at around 300,000. As GQ magazine says, “thanks to a brand reimagining and increased medical research”, the naturally occurring compound has “gone from dangerous to desirable”.
Advocates of CBD oil say it can relieve chronic pain and inflammation, anxiety, depression, insomnia and epilepsy. But many people are confused over the legal status of medicinal cannabis.
Sativa Investments PLC invest in global companies which are well-placed to take advantage of the dynamic regulatory environment surrounding medical cannabis. Their investment strategy focuses on production, pharmacology, testing and compliance, R&D commercialisation, and sales and marketing.